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The detection of unilateral renal disease as a cause of hypertension can still be complicated. Intravenous pyelograms are sometimes normal in the presence of renal ischaemia. The significance of renal artery stenosis when shown by arteriography may be difficult to assess, particularly as not a few normotensive people have similar lesions, and divided clearance studies are still beset by technical difficulties.
The radioisotope renogram was introduced by Winter and his colleagues in 1956 (Taplin et al. 1956 ). In expert hands this is a rapid, safe and often successful method of comparing individual kidney function. Although much has been written about these renograms, considerable controversy surrounds their interpretation.
The use of radioactive chlormerodrin for kidney scanning, using the isotope 203Hg, was first reported in 1960 by McAfee & Wagner. Subsequently, these same workers (Reba et al. 1962 , Reba et al. 1963 ) and Kellershohn and his colleagues (Raynaud et al. 1963 ) measured the uptake of radioactive chlormerodrin by the kidneys with external scintillation counters and were able to predict the presence of unilateral renal disease with considerable accuracy. More recently others (Johnston et al. 1964 , Sodee 1965 have reported favourably on their experience with 197Hg chlormerodrin.
Following intravenous injection chlormerodrin accumulates in the kidneys and reaches a maximum concentration in two to three hours. The concentration then remains fairly constant for a further two to three hours, and it is during this time that a kidney scan can be made by a suitable scanning device. We have used chlormerodrin labelled with 197Hg. This isotope has a half life of 2-7 days. Following an injection of 100 ,uc 197Hg chlormerodrin the irradiation received by the kidneys is approximately 1 rad and the whole body 0-018 rad.
Studies with a pair of phantom kidneys (made from balloons filled with 197Hg chlormerodrin and submerged in water) have shown that the size of the scans and the number of counts are markedly affected by small changes in the depth of the phantoms. A difference in depth of one centimetre produces readily discernible differences in the scans. This means that any method of comparing kidney function that depends on total counts over the kidney or on kidney size is unreliable, as the kidneys may not be the same depth beneath the skin.
Measurement of the rate of uptake of 197Hg chlormerodrin by external scintillation counting over each kidney eliminates this problem, as the rate of uptake is independent of depth. Phantom studies confirm this (Secker-Walker 1966, unpublished observations).
We have, therefore, followed Wagner and his colleagues in measuring the rate of uptake of labelled chlormerodrin before kidney scanning.
Method
For this test the patients require no special preparation apart from an intravenous injection of 1-3pc labelled chlormerodrin for accurate localization of the kidneys. One to two hours after this injection the region of maximal count rate is found by moving a scintillation counter over the back while the patient lies prone. Two matched scintillation counters with wide-angle collimation are then placed over the region of maximum activity on each side.
Radioactive chlormerodrin, equivalent to 1 pc per kilogram body weight is given intravenously patients and the count rate over each kidney recorded for fifty minutes. Two to four hours after the injection scanning is carried out with the patient prone, using a Picker magnascanner, Mark II. The rate of uptake of 197Hg chlormerodrin by each kidney is calculated by dividing the count rate at any time, Ct, with that at five minutes, C5. The rate of uptake on the right, ct RIGHT, is divided by that of the left, ct LEFT, to give a ratio for comparison of the 2 kidneys (Reba et al. 1963) .
Results
Fifty patients have been studied. Twenty of these were considered to have normal kidneys; 16 had normal intravenous pyelograms and renal arteriograms, while the other 4 had normal intravenous pyelograms but no arteriograms. Twelve of these patients had hypertension and the other 8 were normotensive. Fig 6 shows the scan of A B, a woman of 42 with moderately severe hypertension (blood pressure 200/130 mmHg), whose intravenous pyelogram showed that the right kidney was more than 2 cm smaller than the left. The scan also shows the difference in size, but the rate of uptake and the ratio c RIGHT/t5 LEFT were normal, see Fig 7. Renal arteriography was normal. When there is a difference in kidney size, but the rate of uptake of chlormerodrin and ratio Renal artery stenosis and chronic pyelonephritis may produce similar disturbances of the rate of uptake of chlormerodrin, and of the renal scan. This test gives no indication of the cause of the disease in the affected kidney.
Thirty of our patients had abnormalities either of the uptake of labelled chlormerodrin or of the scan, and most of them had abnormalities of both. Twenty-two patients were thought to have unilateral disease and 8 bilateral disease.
Twelve patients had renal artery lesions and all were detected by the uptake part of the test. Two of these had normal kidney scans and intravenous I pyelograms. In one of these the ratio between the 2 kidneys was normal but the rate of uptake was below normal limits; this woman, aged 22, had fibromuscular hyperplasia with an aneurysm on the right renal artery.
Six patients with chronic pyelonephritis and 4 with back pressure atrophy were correctly detected by both parts of the test. In a further group of 6 patients with a variety of lesions either one or both tests detected them all.
There remain 2 patients with abnormal uptakes on the left side but normal intravenous pyelograms and renal arteriograms (though one of these arteriograms showed evidence of small vessel disease). These 2 are false positive results. There have been no false negative results so far.
Conclusions
In this small series our preliminary results are encouraging. Measurement of the rate of uptake of 197Hg chlormerodrin by the kidneys followed by scintillation scanning has proved a reliable guide to the presence of both unilateral and bilateral renal disease in patients with hypertension.
It seems to be of most value in those patients with renal artery stenosis who have normal intravenous pyelograms as these could be selected for arteriography, and it is also of value in those patients with unequal kidneys but normal renal arteries as these patients have normal rates of uptake of 197Hg chlormerodrin and renal arteriography could be avoided. More than forty years ago Keith (1923) demonstrated that chronic anemias and leukaemia were frequently associated with high blood volumes, a finding confirmed by subsequent investigations (Rowntree et al. 1929 , Berlin et al. 1950 , Kelly et al. 1952 ). However, similar work indicating high blood volumes in patients with carcinomata. has been criticized on the grounds that weight-related volumes will appear high in wasted subjects (Price & Greenfield 1958) , since adipose tissue has a relatively small blood content (Gregerson & Nickerson 1950) . In investigating the-blood volumes of patients with splenomegaly, therefore, only subjects of apparently normal nutritional status were included and in addition, the estimated blood volumes were compared with ideal volumes predicted by the height and body weight formula of Nadler et al. (1962) , which are only partially dependent on body weight.
Methods
All estimations of blood volume were made by the addition of estimated red cell mass to plasma volume to avoid error arising from variations in the whole body to venous hematocrit ratio in subjects with splenomegaly. The red cell mass was estimated as the volume of distribution of the subject's own cells labelled with chromium 51 and returned to the circulation intravenously. To ensure adequate mixing of the cells before final blood sampling, radioactivity at the body surface was monitored over the spleen by means of an external scintillation counter, and the quoted values for the red cell mass were calculated from the activity of venous blood samples drawn twenty to fifty minutes after a constant level of radioactivity was attained in the splenic region. Usually this was between fifty and one hundred and twenty minutes after initial injection of the labelled cells.
Plasma volumes were estimated using iodine 131 labelled human serum albumin. Venous hxmatocrit levels were estimated either by microhamatocrit (uncorrected) or by the Wintrobe method, with centrifuging for fifty-five minutes and correcting for plasma trapping by the method of Chaplin & Mollison
